RT Journal Article
SR Electronic
T1 Construction and Validation of a Nomogram Based on the Log Odds of Positive Lymph Based on the Log Odds of Positive Lymph Nodes to Predict the Prognosis of Lung Neuroendocrine Tumors
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.10.12.21264905
DO 10.1101/2021.10.12.21264905
A1 Wang, Suyu
A1 Wei, Juan
A1 Guo, Yibin
A1 Xu, Qiumeng
A1 Lv, Xin
A1 Yu, Yue
A1 Liu, Meiyun
YR 2021
UL http://medrxiv.org/content/early/2021/10/18/2021.10.12.21264905.abstract
AB Objectives This study aimed to investigate the prognostic value of Log odds of positive lymph nodes (LODDS) for predicting the long-term prognosis of patients with node-positive lung neuroendocrine tumors (LNETs).Materials and Methods We collected 506 eligible patients with resected N1/N2 classification LNETs from the Surveillance, Epidemiology, and End Results (SEER) database between 2004 and 2015. First, we applied the Cox proportional-hazards regression model to evaluate the relationship between LODDS and study endpoints (cancer-specific survival [CSS] and overall survival [OS]) based on the entire cohort. Second, the study cohort was divided into derivation cohort (n=300) and external validation cohort (n=206) based on different geographic regions. Nomograms were constructed and validated based on these two cohorts to predict the 1-, 3- and 5-year survival of patients with LNETs. The accuracy and clinical practicability of nomograms were tested and compared by Harrell’s concordance index (C-index), integrated discrimination improvement (IDI), net reclassification improvement (NRI), calibration plots, and decision curve analyses.Results The Cox proportional-hazards model showed the high LODDS group (-0.33≤LODDS≤1.14) had significantly higher mortality compared to those in the low LODDS group (-1.44 ≤LODDS<-0.33) for both CSS and OS. In addition, besides LODDS, age at diagnosis, histotype, type of surgery, radiotherapy, and chemotherapy were shown as independent predictors in Cox regression analyses and included in the nomograms. The values of c-index, NRI, and IDI indicated that the established nomogram performed significantly better than the conventional eighth edition of the TNM staging system alone. The calibration plots for predictions of the 1-, 3-, and 5-year OS were in excellent agreement. Decision curve analyses showed that the nomogram had value in terms of clinical application.Conclusions We created visualized nomograms for CSS and OS of LNET patients, facilitating clinicians to provide highly individualized risk assessment and therapy.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by Development Fund for the Department of Anesthesiology of Shanghai Pulmonary Hospital. The funders have no role in the study design, data collection, data analysis and completion of the manuscripts.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authorsAbbreviationsLNETlung neuroendocrine tumorTCtypical carcinoidACatypical carcinoidLCNEClarge cell neuroendocrine carcinomaSCLCsmall cell lung carcinomaNSCLCnon-small cell lung cancerAJCCAmerican Joint Committee on CancerUICCUnion for International Cancer ControlTNMtumor-node-metastasisLNlymph nodeNPLNnumber of positive lymph nodeLODDSlog odds of positive lymph nodesSEERSurveillance, Epidemiology, and End ResultsNDLNnumber of dissected lymph nodeCSSlung cancer-specific survivalOSoverall survivalSDstandard deviationIQRinterquartile rangeHRhazard ratioCIconfidence intervalPRCDApurchased/referred care delivery areac-indexconcordance indexIDIintegrated discrimination improvementNRInet reclassification improvementDCAdecision curve analysisLNRlymph node ratioIASLCInternational Association for the Study of Lung Cancer